An Act prohibiting clinical laboratory self-referrals
The committee on Public Health to whom was referred the petition (accompanied by bill, Senate, No. 1013) of Barry R. Finegold, Attorney General Martha Coakley, Gale D. Candaras, Karen E. Spilka and other members of the General Court for legislation to prohibit clinical laboratory self-referrals and (accompanied by bill, House, No. 1950) of John V. Fernandes and others relative to prohibiting clinical laboratory self-referrals reports the accompanying bill of the same title (Senate, No. 1932).
Whereas, The deferred operation of this act would tend to defeat its purpose, which is to prevent clinical laboratory self-referrals, therefore, it is hereby declared to be an emergency law, necessary for the immediate preservation of the public health.
|11/21/2013||Senate||Reported from the committee on Public Health|
|11/21/2013||Senate||New draft of H1950 and S1013|
|11/21/2013||Senate||Bill reported favorably by committee and referred to the committee on Health Care Financing|
|5/8/2014||House||Reporting date extended to Monday June 30, 2014, pending concurrence|
|7/3/2014||Senate||Committee recommended ought to pass with an amendment, substituting a new draft, see S2236|
|7/3/2014||Senate||Referred to the committee on Senate Ways and Means|
|1/6/2015||Senate||No further action taken|
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.